Kevin Hern: “It is on us to go after market share and create access for our products around the world.”

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.

It is critical that we keep innovation here in the U.S., but it is also critical that we make sure healthcare is affordable.

It’s what the president got elected on.

I will always advocate for those who are suffering from a rare disease and support efforts to bring treatments for these diseases to market.